BTC Health Ltd
ASX:BTC

Watchlist Manager
BTC Health Ltd Logo
BTC Health Ltd
ASX:BTC
Watchlist
Price: 0.054 AUD Market Closed
Market Cap: AU$19.3m

EV/IC

1.8
Current
25%
Cheaper
vs 3-y average of 2.5

Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.

EV/IC
1.8
=
Enterprise Value
AU$18.1m
/
Invested Capital
AU$9.6m

Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.

EV/IC
1.8
=
Enterprise Value
AU$18.1m
/
Invested Capital
AU$9.6m

Valuation Scenarios

BTC Health Ltd is trading below its 3-year average

If EV/IC returns to its 3-Year Average (2.5), the stock would be worth AU$0.07 (33% upside from current price).

Statistics
Positive Scenarios
3/4
Maximum Downside
-7%
Maximum Upside
+74%
Average Upside
28%
Scenario EV/IC Value Implied Price Upside/Downside
Current Multiple 1.8 AU$0.05
0%
3-Year Average 2.5 AU$0.07
+33%
5-Year Average 2.1 AU$0.06
+12%
Industry Average 3.2 AU$0.09
+74%
Country Average 1.7 AU$0.05
-7%

Forward EV/IC
Today’s price vs future invested capital

Not enough data available to calculate forward EV/IC

Peer Comparison

All Multiples
EV/IC
P/E
All Countries
Close
Market Cap EV/IC P/E
AU
BTC Health Ltd
ASX:BTC
19.3m AUD 1.8 -18.5
US
GE Vernova LLC
NYSE:GEV
291.1B USD 0 0
UK
Eight Capital Partners PLC
F:ECS
158.4B EUR 0 0
US
China Industrial Group Inc
OTC:CIND
121B USD 1 028.6 4 020.7
NL
Nepi Rockcastle NV
JSE:NRP
100.2B ZAR 0.9 10.4
US
Fintech Ecosystem Development Corp
NASDAQ:FEXD
67.9B USD 1 656.4 38 368.9
US
CoreWeave Inc
NASDAQ:CRWV
56B USD 0 0
CH
Galderma Group AG
SIX:GALD
38.4B CHF 0 0
US
Coupang Inc
F:788
31.4B EUR 6.1 173.5
US
Symbotic Inc
NASDAQ:SYM
35.6B USD 36.9 -3 256.9
ZA
Vukile Property Fund Ltd
JSE:VKE
29.7B ZAR 1 6.9
P/E Multiple
Earnings Growth PEG
AU
BTC Health Ltd
ASX:BTC
Average P/E: 8 516.1
Negative Multiple: -18.5
N/A N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available
19%
N/A
UK
E
Eight Capital Partners PLC
F:ECS
Not Available N/A N/A
US
C
China Industrial Group Inc
OTC:CIND
4 020.7
N/A N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
10.4
1%
10.4
US
F
Fintech Ecosystem Development Corp
NASDAQ:FEXD
38 368.9
N/A N/A
US
C
CoreWeave Inc
NASDAQ:CRWV
Not Available N/A N/A
CH
G
Galderma Group AG
SIX:GALD
Not Available
47%
N/A
US
Coupang Inc
F:788
173.5
96%
1.8
US
Symbotic Inc
NASDAQ:SYM
Negative Multiple: -3 256.9 N/A N/A
ZA
V
Vukile Property Fund Ltd
JSE:VKE
6.9
-5%
N/A

Market Distribution

In line with most companies in Australia
Percentile
52nd
Based on 2 047 companies
52nd percentile
1.8
Low
0 — 1.1
Typical Range
1.1 — 3.5
High
3.5 —
Distribution Statistics
Australia
Min 0
30th Percentile 1.1
Median 1.7
70th Percentile 3.5
Max 3 073.7

BTC Health Ltd
Glance View

Market Cap
19.3m AUD
Industry
N/A

BTC Health Ltd is a AU-based company operating in industry. The company is headquartered in Hawthorn, Victoria. The company went IPO on 2000-08-29. BTC health Limited is a Australian pooled development fund. The firm hold investments, and continues to actively seek investment opportunities in the healthcare sector. The firm holds active interests in two investment companies, which includes BTC Speciality Health Pty Ltd and BioImpact Pty Ltd. BTC Speciality Health Pty Ltd is a distributor of medical devices and consumables in the Australian and New Zealand Public and Private Hospital market. The firm has a range of medical consumables, such as Bronchitol, Aridol and Breg braces, which has been sublicensed from BioImpact Pty Ltd. BioImpact Pty Ltd is an investment company, which licenses and holds intellectual property rights for healthcare products.

BTC Intrinsic Value
0.011 AUD
Overvaluation 80%
Intrinsic Value
Price AU$0.054
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett